- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Medco licenses new radiopharmaceutical
Drug developer Medco Research has acquired a new technetium-basedcardiac radiopharmaceutical, the Research Triangle Park, NC, companyannounced last week. Medco acquired the agent through a licensingdeal with the product's developer, Molecular Targeting
Drug developer Medco Research has acquired a new technetium-basedcardiac radiopharmaceutical, the Research Triangle Park, NC, companyannounced last week. Medco acquired the agent through a licensingdeal with the product's developer, Molecular Targeting Technologyof Malvern, PA. The drug, called technetium-99m Glucarate, isdesigned for the early diagnosis of acute myocardial infarctionand is in phase-I clinical trials.
Medco will have exclusive worldwide rights to develop, manufactureand market the agent. Molecular Targeting will retain rights inAsia, with the exception of Japan.
Another Medco cardiac imaging agent, ViaScint, has completedphase-III trials and the company is planning to file a new drugapplication shortly. ViaScint is designed to help predict whichpatients will have improvement in cardiac function following revascularization.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.
Could a Newly FDA-Cleared C-Arm Device Bolster Efficiency for Interventional Radiologists?
April 22nd 2024In addition to advanced imaging quality and dose efficiency, the Philips Zenition 30 mobile C-arm device emphasizes personalized user profiles and automated customization to help reduce procedure time.
